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Introduction 
Abnormal cleavage patterns exhibited by some embryos include, but are not limited to; 
abnormal syngamy, direct cleavage (DC), reverse cleavage (RC), absent cleavage in the 
presence of karyokinesis (AC), chaotic cleavage (CC) and cell lysis (CL).  
The first of five abnormal cleavage patterns investigated here is direct cleavage (DC). 
This is the cleavage of one blastomere into three, instead of the expected two, daughter 
cells (supplementary figure 1). The ability of these embryos to create a pregnancy has 
been shown to be significantly reduced (Rubio et al., 2012) where 13.7% (715/5225) of 
  
all examined embryos and 6.6% (109/1659) of transferred embryos underwent DC, with 
1.2% (1/109) resulting in a clinical pregnancy. These embryos have been shown to have 
a markedly decreased blastocyst formation rate when compared to their normal 
counterparts (Athayde Wirka et al., 2014).  
The second abnormal phenotype to be considered is reverse cleavage (RC); the 
phenomenon of blastomere fusion (supplementary figure 1). Of 789 embryos assessed 
for RC, defined as blastomere fusion or failed cleavage, 27.4% of embryos were found to 
exhibit this abnormal cleavage pattern and were shown to have a reduced implantation 
potential (Liu et al., 2014). An examination of 1698 embryos detected a prevalence of RC 
of 6.8% however embryos appeared to have similar fragmentation, cell evenness and 
morphokinetic profiles compared to their non reverse cleaved counterparts (Hickman et 
al., 2012). This research concluded that RC does not seem to impair embryo 
development to the blastocyst stage supported by the findings of others (Desai et al., 
2014). 
Absent cleavage (AC) is defined as the process by which a blastomere undergoes a 
pseudo division (seen as a ‘roll’) that does not produce two discernable blastomeres but 
a single, or multiple, extra nuclei within the single blastomere (supplementary figure 1). 
AC has previously been categorised under RC, termed type II RC (Liu et al., 2014). Of 
those embryos that underwent RC (27.4%, (216/789), 82% were classed as type II; 
absent cleavage rather than blastomere fusion. Further evidence of this specific 
developmental pattern has not yet been published perhaps due to the likelihood that 
these embryos will be used for treatment.  
Chaotic cleavage (CC) results when an embryo undergoes apparent cleavage but does 
not create distinctive blastomeres (supplementary figure 1). A single investigation 
studying this cleavage pattern in 639 embryos found an overall prevalence of 15%, a 
blastocyst formation rate of 14% and an implantation rate (IR) of 0% (Athayde Wirka et 
al., 2014). Interestingly, this investigation also found that 35.2% of those exhibiting CC 
had good cleavage stage quality. This was however, markedly lower than the other 
abnormal phenotypes observed (DC and abnormal syngamy). Again, as with AC, this 
phenomenon may be under investigated due to the likelihood that embryos exhibiting this 
phenotype will be used in treatment.  
Finally, an abnormal embryo developmental phenomenon that has yet to be discussed in 
the literature, in terms of time lapse imaging of embryos from fresh treatment cycles, is 
cell lysis (CL) (supplementary figure 1); a process often visualized in frozen thawed 
embryos (Bottin et al., 2015; Rienzi et al., 2005; Tang et al., 2006; Yeung et al., 2009). In 
an analysis of 891 frozen embryo transfer (FET) cycles, no pregnancies resulted if CL 
occurred in over 50% of the embryo. However, if CL accounted for 25 to 50% of the 
embryo the pregnancy rate was 3.2%; significantly lower than if less than 25% CL had 
occurred (16.6%) (Tang et al., 2006) supported by others (Bottin et al., 2015; Yeung et 
al., 2009).  
 
Although these investigations are not entirely synonymous with the current analysis, they 
provide evidence that embryos with lysed cells have a reduced implantation potential.  
 
As discussed above, there is disparity in the literature with regards to the prevalence and 
implication of the presence of certain abnormal phenotypes. Further investigation into 
these phenomena is required to determine if their presence is severe enough to exclude 
these embryos from selection for use in treatment. Five abnormal cleavage patterns 
  
exhibited by embryos (DC, RC, AC, CC and CL) are explored in 15,819 embryos 
detailing their prevalence, implantation potential, and the suitability for inclusion of these 
potential deselection criteria in embryo selection models.  
 
Materials and Methods 
This investigation was a single site, retrospective observational design approved by the 
North West Research Ethics Committee (ref: 14/NW/1043) as well as Institutional Review 
Board approval. All procedures and protocols complied with UK regulation (Human 
Fertilisation and Embryology Act, 1990, 2008). Data were obtained from 5131 treatment 
cycles including 15,819 embryos cultured in the EmbryoScope® incubators between 
January 2014 and January 2016. 
 
Ovarian Stimulation  
Pituitary down regulation was achieved using either a gonadotrophin releasing hormone 
agonist (buserelin, Suprecur®, Sanofi Aventis, UK) or antagonist (cetrorelix acetate, 
Cetrotide®, Merck Serono, Germany). Ovarian stimulation was performed using urine 
derived or recombinant follicle stimulating hormone (Progynova (Bayer, Germany), 
Fostimon, Merional (IBSA, Switzerland), Menopur® (Ferring Fertility, Switzerland), Gonal 
f® (Merck Serono). Doses were adjusted based on patient demographic and response. 
Patients were given 5000IU of subcutaneous hCG (Gonasi® HP, IBSA Pharmaceuticals, 
Italy) 36 hours prior to oocyte collection. Luteal support was provided using 400mg of 
progesterone pessaries twice daily (Cyclogest®, Actavis, UK) until the pregnancy test 
was performed.  
 
Oocyte retrieval and embryology  
Ultrasound guided oocyte collection was performed transvaginally under sedation 
(Diprivan, Fresenius Kabi, USA). Collected oocyte cumulus complexes were cultured in 4 
well dishes (Nunc™, Thermo Scientific, USA) each well containing 0.65ml GIVF™ 
(Vitrolife, Gothenburg, Sweden) covered with 0.35ml OVOIL™ (Vitrolife) in a standard 
incubator (Sanyo Multigas MCO 18M). Sperm preparation was performed using a 
standard gradient separation (ISolate®, Irvine Scientific, USA) at 0.3 relative centrifugal 
force (rcf) for ten minutes followed by two washes at 0.6rcf for ten minutes using GIVF™. 
Those oocytes destined for ICSI were prepared using enzymatic (HYASE 10X™, 
Vitrolife) and mechanical digestion. ICSI was performed on all metaphase II oocytes (MII) 
approximately four hours following collection after which time all injected oocytes were 
placed in individual culture drops of G1™ (for all cycles pre September 2014) or GTL™ 
(all cycles post September 2014) (Vitrolife) and cultured in the EmbryoScope® (Vitrolife). 
Those oocytes destined for standard insemination (IVF) had this performed 
approximately four hours after collection and were replaced into a standard incubator 
until fertilisation check the following day. Oocytes were then checked for fertilisation 
approximately 16 to 18 hours post insemination (hpi) and all fertilised oocytes along with 
all unfertilised metaphase II oocytes were placed in individual culture drops as with ICSI 
derived embryos and cultured in the EmbryoScope®. Embryo selection was performed 
using the national grading scheme (ACE/BFS guidelines (Cutting et al., 2008)) along with 
an internally derived, ESA. This ESA was used as an additive to morphology with the 
latter remaining the gold standard. This ESA included three morphokinetic parameters; 
s2 (time between t3 and t4), cc3 (time between t4 and t5) and t5 with embryos graded in 
one of eight categories from A+ to D-. Embryo transfer was performed using the highest 
  
grade embryo(s) either three or five days post collection depending on the number of 
good quality embryos the patient had on day three as well as how many were to be 
transferred. Selected embryos were cultured in EmbryoGlue® (Vitrolife) for 10 to 30 
minutes in a standard incubator prior to embryo transfer. Embryos were cultured at 37°C, 
6% CO2, 5% O2, 89% N2 throughout.  
 
Analysis of time lapse information 
The image interval on the EmbryoScope® was set to 10 minutes with seven focal planes. 
Images were collected for the duration of culture immediately following ICSI or 
fertilisation check (for IVF derived embryos) to utilisation. Images were assessed by an 
embryologist for the abnormal embryonic phenotypes of interest. For DC, embryos were 
classified into one of three categories; true DC (TDC, defined as all three resultant cells 
cleaving on the subsequent cell cycle, each having a nucleus and each included in the 
morula), false DC (FDC, one or more of the above criteria not fulfilled) and unconfirmed 
DC (UDC, unable to classify as true or false). UDC embryos were defined as such due to 
either obscurity preventing categorisation or the cessation of culture before the morula 
stage was reached (supplementary figure 1). 
 
Outcome measures and statistical analysis 
The overall prevalence of the five abnormal embryo phenotypes was defined per embryo 
and per treatment cycle. The average patient age, oocytes collected and previous 
attempts were calculated for each of the five categories. The fate (transfer, freeze, 
discard) of each abnormal embryo was determined as well as their quality on the day of 
utilisation defined as good, average or poor (supplementary table 1). The IR for each 
abnormal phenotype was determined where the origin of the fetal heart could be 
confirmed i.e. using known implantation data from an abnormal embryo or not. The 
number of single and double abnormal embryo transfers and the stage at which the 
abnormal embryo(s) was transferred was also determined (supplementary table 2). 
Statistical analyses included the student t test for the comparison of the abnormal 
phenotype baseline information (patient age, oocytes collected and previous attempts) to 
the control embryo baseline data. The Fisher’s exact test was used to compare the IR of 
the abnormal embryos with normal counterparts. Results were considered statistically 
significant at p<0.05. Statistical analysis was performed using the statistical package 
Prism® 5 (GraphPad Software©, USA). 
 
Results 
Data were obtained from 15,819 embryos from 5131 treatment cycles cultured in the 
EmbryoScope® between January 2014 and January 2016. Of the 15,819 embryos, 
14,008 were derived from 3273 treatment cycles where no abnormal divisions of interest 
(DC, CC, RC, AC and CL) were observed and thus constituted the control group. These 
embryos resulted in 3456 embryos transferred and 1336 fetal heartbeats (IR= 38.66%) 
(table 1). The remaining embryos (1811) were found to pertain to a treatment cycle 
(n=1286) exhibiting an embryo with one of the abnormal division patterns of interest.  
 
Abnormal phenotypes with the highest prevalence per embryo observed were DC and 
CC at 4.38% (TDC, FDC, UDC, collectively) and 5.25%, respectively. The remaining 
phenotypes had considerably lower prevalence ranging from 0.41 to 0.84% (table 3). The 
overall prevalence per embryo observed of abnormal division patterns was 11.39% (table 
  
3). The IR of abnormal embryos ranged from 0 to 33.3% (table 3). Of the five abnormal 
division patterns the IR of UDC, CC and RC were significantly lower than normal 
counterparts; 12.5% (2/16), 2.1% (1/48) and 0% (0/9), respectively (table 3). 
Furthermore, the overall IR of all abnormal embryos was statistically significantly lower 
than normal counterparts (6.9% (6/86) vs 38.66%) (table 1 and 3). In all cases the 
percent of good quality embryos resulting from those exhibiting abnormal division 
patterns never reached above 24% and the majority of embryos were classified as poor 
quality (table 3). This is also reflected in the utilisation of these embryos where the 
highest proportion of each group was discarded (supplementary figure 2).  
 
Patient age was statistically significantly lower for those undergoing DC, RC and CC to 
those not exhibiting an abnormal division pattern. The number of oocytes collected was 
found to be statistically significantly higher in treatment cycles containing abnormal 
embryos than those not containing embryos exhibiting an abnormal division pattern. 
Finally, the number of previous attempts was not found to be statistically significantly 
different between any of the abnormal division categories and the control embryo cohort 
(table 2). Baseline information from treatment cycles containing an abnormal embryo did 
not contribute to baseline information for the control cohort. 
 
Discussion 
The prevalence of DC in the literature has been stated as 13.7% (Rubio et al., 2012) and 
18% (Hickman et al., 2012). In the current analysis the overall prevalence of DC was 
4.38% (UDC, FDC and TDC combined) occurring in 1.22 embryos per treatment cycle. 
The implantation potential of embryos undergoing DC has been stated as just 1.2% 
(Rubio et al., 2012) however, in the current analysis the IR was found to be 17.4% (4/23) 
(TDC, FDC and UDC combined); not statistically significantly lower than that of the 
control embryo cohort although this could be attributed to the reduced numbers. A 
classification system of DC was not adopted by other publications therefore if FDC were 
not considered, the IR would be statistically significantly lower than those not exhibiting a 
DC. Of the three categories, those that were classed as FDC had the highest IR, as one 
might expect from the definition. Genetic assessment of DC oocytes has revealed three 
division patterns; DC to three cells (62%); cleavage to a morphologically normal two cell 
‘embryo’ (24%) and cleavage to a two cell ‘embryo’ plus an extrusion (14%) (Kola et al., 
1987). All triploid oocytes that had undergone DC to three cells were chromosomally 
abnormal with each containing a varied number of chromosomes (here considered a 
TDC). Those that cleaved to morphologically normal two cell ‘embryos’ were found to be 
true triploid with each blastomere containing a 69XXX/XXY chromosome complement. 
However, of those oocytes that cleaved to a two cell ‘embryo’ plus an extrusion, 75% 
were found to have two diploid blastomeres and a haploid extrusion. In the analysis 
presented here, the IR of FDC, those embryos analogous to the two cell embryo plus an 
extrusion, was 33.3% (2/6). Caution should be taken as the numbers are very reduced in 
this group due to the need to use known implantation embryos, however, this represents 
a result just over 5% lower than that of a phenotypically normal embryo. The findings by 
Kola et al. (1987) may indicate that embryos could have the potential to correct genetic 
abnormalities. There are many studies detailing self correction between the cleavage 
stage and the blastocyst stage of embryo development (Barbash-Hazan et al., 2008; Li et 
al., 2005; Munne et al., 2005; Northop et al.,2010; Voullaire et al., 2000). It has been 
noted that trisomy embryos correct more often than other aneuploidies (Barbash-Hazan 
  
et al., 2008) possibly occurring through the loss of a chromosome in trisomy cells (Munne 
et al., 2005). In addition, in previous reports, CC could be misinterpreted as a DC thus 
causing the prevalence of DC to appear falsely increased. The increased IR of DC seen 
in the present investigation compared to previous reports may also be due to observers 
having experience with the different categorisations of DC, making them proficient at 
recognising patterns of FDC, such as blastomere behavior, allowing preferential selection 
of a potential FDC in UDC cases. The reduced patient age and increased number of 
oocytes collected may reflect a simple association between maternal age and number of 
oocytes collected. However, it may also indicate that stimulation can lead to reduced 
oocyte quality (Aboulghar et al., 1997) and high oocyte numbers (>15) can reduce the 
chance of a live birth (Ji et al., 2013) which could manifest as an abnormality such as 
DC.  
 
RC occurred in 65 embryos (1.07 embryos per treatment cycle) of which 36 were either 
transferred or frozen where 26 were classed as good or average quality. It is likely that 
embryos classed as PQE were utilised due to unavailability of others. The IR of embryos 
undergoing RC in the current investigation was 0% (0/9). The prevalence of RC has been 
reported as 6.8, 7 and as high as 27.4% in previous reports (Desai et al., 2014; Hickman 
et al., 2012; Liu et al., 2014). However, the rate of formation of usable embryos is in 
conjunction with others at approximately 40% (Desai et al., 2014). There have been 
reports that RC is affected by other variables such as ICSI and GnRH antagonists. 
Therefore a possible explanation for the disagreement presented here could be due to 
the difference in baseline patient and treatment variables, a consideration for further 
investigation. The phenomenon of RC has been recognised previously with regards to 
frozen thawed embryos (Balakier et al., 2000; Trounson, 1984). Balakier et al. (2000) 
sought to determine the chromosomal changes in blastomeres that undergo fusion 
following thawing. This analysis included 1141 embryos frozen on day two and 873 
frozen on day three. RC was found in 51 embryos of which 70% were classed as good 
quality. The overall frequency of RC was 4.6% in day two embryos and 1.5% in day three 
embryos. A slightly higher incidence of blastomere fusion was found in embryos created 
using IVF when compared to ICSI. When a control group was observed (embryos not 
subject to freezing and thawing) the prevalence of RC was 0.3%, a result not far from 
that recorded in the present study (0.41%). The IR of embryos that underwent 
blastomere fusion following thawing in the above investigation was very poor with 15 
embryo transfers containing one abnormal and one normal embryo resulting in a single 
live birth only. Again, a result similar to that seen in the present investigation where no 
pregnancies resulted from nine embryos transferred that had undergone RC. The 
chromosomal status of blastomeres resulting from fusion was also examined where 
embryos affected by RC were transformed into either polyploidy or mosaics embryos. 
The authors suggested that the occurrence of blastomere fusion could be associated 
with existing membrane abnormalities that could promote fusion affected by factors such 
as pH, temperature and osmolality differences. Interestingly, in some fields of research 
the production of tetraploid embryos is advantageous and it has been concluded that 
tetraploidy does not prohibit preimplantation development (Eglitis, 1980); corroboration 
for the development of approximately 40% G/AQE in the present investigation. This 
investigation could conclude similarly to others where the presence of RC did not seem 
to affect an embryos ability to create a GQE but does impair an embryos ability to 
implant.  
  
 
Absent cleavage has been characterised as a type of RC in a previous report (Liu et al., 
2014) however, in the current report it is classed as a distinct phenotype. The prevalence 
per embryo of this abnormality compared to RC is more than double (0.84 vs 0.41%) and 
of the four embryos that were transferred with this phenotype, one implanted. However, 
in a previous report, of 22 embryos, none implanted that underwent type I or type II RC 
(defined here as AC) (Liu et al., 2014). In another investigation using disaggregated 
human embryos, blastomeres were scored for the number of nuclei present after 16 to 
20h culture and a small proportion of mononucleated blastomeres exhibited two nuclei 
after culture. It was hypothesised that approximately 30% of these occurred through AC 
(Pickering et al., 1995). Here, AC was shown to occur in 1.08 embryos per treatment 
cycle and of the 133 embryos exhibiting AC, 122 were classed as PQE and 116 were 
discarded. Unlike DC, RC and CC however, the patient age was not shown to be 
significantly different when compared to the control embryo cohort.  
 
CC has an overall prevalence per embryo of 5.25%; by far the highest of the five 
abnormal phenotypes. Occurring in 1.82 embryos per treatment cycle suggestive of a 
patient, treatment or environmental effect rather than a spontaneous event. One 
comprehensive analysis identified the prevalence of CC to be 15%, with a blastocyst 
formation rate of 14% and an IR of 0% (Athayde Wirka et al., 2014). In the current 
analysis, the IR of these embryos was 2.1% (1/48); statistically significantly lower than 
the IR of the control embryo cohort. Of the transferred embryos, just 4.7% were classed 
as GQE, 22.4% as AQE and 72.9% as PQE. Interestingly, it has previously been found 
that 35.2% of those exhibiting CC were classed as good quality, a result not synonymous 
with the current analysis. A possible explanation for this disagreement is the time lapse 
technology used. In the current analysis, EmbryoScope® was the time lapse technology 
of choice however, in the analysis by Athayde Wirka et al. (2014) the Eeva™ system was 
used. The Eeva™ system uses dark field illumination to enable the software within it to 
track blastomeres. The EmbryoScope® does not use dark field illumination which could 
make distinction of blastomeres from fragments more straightforward. An investigation 
conducted on patients carrying a Robertsonian translocation (the fusion of two 
acrocentric chromosomes), revealed that a high proportion of embryos resulting from 
these patients underwent numerous chaotic cleavage divisions and rather than the 
aneuploid segregation of the Robertsonian translocation being the only reason for the 
infertility, there may be a post zygotic manifestation leading to uncontrolled chromosome 
segregation (Conn et al., 1998). The presence of chaotically dividing embryos has been 
noted elsewhere (Delhanty et al., 1997; Harper and Delhanty, 1996; Laverge et al., 1997) 
and has also been identified as a patient related phenomenon (Delhanty et al., 1997) a 
statement synonymous with CC occurring in up to 1.82 embryos per treatment cycle.   
 
CL is largely discussed in the literature when considering frozen thawed embryos and, as 
discussed previously, there is an associatively low IR (Tang et al., 2006). 59.2% of the 
embryos were classed as PQE with 55.6% of the total discarded. Just 13.6% were 
considered GQE and 27.2% AQE, a result similar to other abnormal phenotypes. As very 
few embryos were shown to exhibit this phenotype, and fewer still were transferred, it is 
difficult to draw conclusions about the implications of this abnormal phenotype. It would 
be reasonable to use previous evidence regarding frozen thawed embryos to attribute 
their potential for success. However, CL in frozen embryos is likely as a result of 
  
cryodamage during the freeze thaw process whereas, in fresh embryos, the CL could be 
as a result of exposure to another stressor such as suboptimal pH, temperature or 
osmolality. Cells that lyse may have a heightened sensitivity to changes in the 
environment, or lack a cytoplasmic constituent that regulates cell volume, for example, 
leading to its lysis.  
Abnormal phenotypes as deselection criteria 
Where possible, UDC and TDC embryos should not be selected for transfer if other 
embryos are available, even when embryo quality is considered. CC, the most common 
abnormal phenotype in the current analysis, has been linked to severe chromosomal 
abnormalities in the literature which could be patient specific therefore it’s possible that 
the phenomenon could occur more than once in a patient cohort indicating an underlying 
genetic condition. Where CC embryos are transferred the expected IR is 2.1% regardless 
of embryo quality. For this reason, identification of CC as a deselection tool should be 
considered for laboratories utilising time lapse imaging technologies. Just fewer than 
92% of embryos that exhibit AC create PQE thus they would likely be automatically 
discounted from clinical use. RC and CL each have an IR of 0%, albeit from low numbers 
of transferred embryos. However, the relative prevalence is low, the majority of embryos 
exhibiting these phenomenons are PQE and they are not able to implant therefore these 
embryos should not be selected for transfer where possible. These recommendations 
have been implemented at the study site to aid in embryo selection.  
 
This preliminary investigation sought to determine the prevalence, implantation potential 
and suitability for inclusion in embryo selection algorithms of five abnormal cleavage 
events. To determine IR, only known implantation embryos were used leading to a 
significant reduction in the number of embryos available for analysis. Nevertheless, this 
number would be difficult to achieve at another single site based on the study site using 
time-lapse for all patients and performing over 2000 treatment cycles per year. Based on 
the results presented here, future analyses should focus on embryos undergoing more 
than one abnormal division event, the cell stage at which the abnormal cleavage event 
occurs, the effect of treatment parameters such as ICSI and day of transfer as well as the 
assessment of a relationship between the abnormal phenotypes and multinucleated 
blastomeres.  
 
In conclusion, embryos exhibiting an abnormal phenotype appear to have reduced 
developmental capability expressed as both embryo quality and implantation potential. 
Time lapse systems are bringing to light many unusual and, most likely, fundamentally 
complicated embryological phenomena requiring in depth analysis that could ultimately 
improve the outcome of treatment cycles.  
 
Appendix: Supplementary material 
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Total embryos (n) 14008 
      Embryos transferred (n) 3456 
Embryo transfers (n) 3273 
Sum fhs (n) 1336 
Count fhs (n) 1269 
IR (%) 38.66 
CPR (%) 38.77 
Table 1. Baseline information for embryos not exhibiting an abnormal division pattern Including total number of embryos, number of embryos 
transferred, number of embryo transfers, total fetal heartbeats (fhs), count of fhs (regardless of number), implantation rate (IR), clinical 
pregnancy rate (CPR). IR was calculated as sum fhs/embryos transferred. CPR was calculated as count fhs/embryo transfers.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Affected 
embryos (n) 
Treatment 
cycles (n) 
Patient age 
(mean ± S.D) 
p-value Oocytes collected 
(mean ± S.D) 
p-value Previous attempts 
(mean ± S.D) 
p-value 
TDC 48 45 
32.82 ± 4.7 <0.0001 12.95 ± 7.78 <0.0001 1.37 ± 0.93 >0.05 FDC 69 64 
UDC 580 463 
RC 65 61 32.5 ± 4.5 0.0097 15.7 ± 9.7 <0.0001 1.23 ± 0.6 0.2663 
AC 133 95 33.16 ± 5.41 0.0629 15.09 ± 8.57 <0.0001 1.35 ± 0.8 0.8438 
CC 835 459 32.93 ± 4.87 <0.0001 13.44 ± 8.5 <0.0001 1.39 ± 0.82 0.6765 
CL 81 71 33.24 ± 4.27 0.1381 13.86 ± 7.79 <0.0001 1.28 ± 0.78 0.4422 
Normal 14008 3273 34.08 ± 4.73 - 10.5 ± 5.99 - 1.37 ± 0.98 - 
Table 2. Baseline information for embryos undergoing an abnormal division pattern including the total number of affected embryos, the number 
of treatment cycles these pertain to, the mean patient age, oocytes collected and previous attempts. The mean patient age, oocytes collected 
and previous attempts were statistically analysed against the normal embryo cohort for significant differences (student t-test, significant at 
p<0.05).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Embryos 
(n) 
Cycles 
(n) 
Affected 
embryos/cycle 
Prevalence/ 
embryo (%) 
Prevalence/cycle 
(%) 
Transfer Freeze Discard GQE 
(n 
(%)) 
AQE 
(n 
(%)) 
PQE 
(n 
(%)) 
Abnormal 
embryos 
transferred (n) 
FHS 
(n) 
IR 
(%) 
p-value 
TDC 48 45 1.07 0.3 0.9 3 11 34 10 
(20.8) 
8 
(16.7) 
30 
(62.5) 
1 0 0 >0.05 
FDC 69 64 1.08 0.43 1.2 9 29 31 11 
(16.0) 
21 
(30.4) 
37 
(53.6) 
6 2 33.3 >0.05 
UDC 580 463 1.25 3.65 9.0 33 70 477 69 
(11.9) 
101 
(17.4) 
410 
(70.7) 
16 2 12.5 0.0378 
DC 697 572 1.22 4.38 11.1 45 110 542 90 
(12.9) 
130 
(18.7) 
477 
(68.4) 
23 4 17.4 0.05 
RC 65 61 1.07 0.41 1.2 14 22 29 15 
(23.1) 
10 
(15.4) 
40 
(61.5) 
9 0 0 0.0153 
AC 133 123 1.08 0.84 2.4 7 10 116 6 
(4.5) 
5 
(3.8) 
122 
(91.7) 
4 1 25 >0.05 
CC* 835 459 1.82 5.25 8.9 85 69 681 4 
(4.7) 
19 
(22.4) 
62 
(72.9) 
48 1 2.1 <0.0001 
CL 81 71 1.14 0.51 1.4 5 31 45 11 
(13.6) 
22 
(27.2) 
48 
(59.2) 
2 0 0 0.5257 
Overall 1811 1286 1.41 11.39 25.0 156 242 1413 - - - 86 6 6.9 <0.0001 
Table 3. Descriptive data regarding embryos that underwent an abnormal division pattern. The total number of affected embryos, number of 
affected treatment cycles, the number of affected embryos per treatment cycle, prevalence per embryo (defined as number of affected 
embryos/total number of embryos), prevalence per cycle (defined as number of affected treatment cycles/total number of treatment cycles), 
their fate, their quality and the IR of transferred embryos that were abnormal is shown. The IR of these embryos was then compared to that of 
the normal embryo cohort for statistical significance (Fisher’s exact, significant at p<0.05). 
*only transferred embryos assessed for quality for this category due to significant missing data. 
Supplementary figure 1 
 
Supplementary figure 1; a schematic representation of five categories of 
abnormal embryo phenotypes. A. Direct cleavage; cleavage of one 
blastomere into three distinct blastomeres. B. Reverse cleavage; the fusion of 
two blastomeres into a single blastomere. C. Absent cleavage; pronuclear/ 
nuclear fading followed by a cytoplasmic ‘roll’, no division, but an additional, or 
multiple, nuclei. D. Chaotic cleavage; cleavage of one cell into multiple 
fragments with no discernable blastomeres. E. Cell lysis; the lysing of one 
blastomere within an embryo at any stage of development.  
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Supplementary figure 2 
 
 
 
 
 
 
 
Supplementary figure 2. Fate of embryos exhibiting abnormal phenotypes. 
Proportion of embryos transferred, frozen or discarded that underwent an 
abnormal division pattern where direct cleavage (DC) includes true direct 
cleavage (TDC), false direct cleavage (FDC) and unconfirmed direct cleavage 
(UDC) combined. RC; reverse cleavage, AC; absent cleavage, CC; chaotic 
cleavage, CL; cell lysis.  
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Good quality embryos 
(GQE) 
Cleavage stage embryos with even blastomeres (<20% 
difference in diameter) and <20% fragmentation 
Blastocyst embryos with prominent and compact inner cell 
mass and many cells forming a cohesive epithelium 
Average quality embryos 
(AQE) 
Cleavage stage embryos with 20-50% difference in cell 
diameter and/or 20-50% fragmentation 
Blastocyst stage embryos with easily discernable inner cell 
mass with many cells that are loosely grouped together 
Poor quality embryos (PQE) Cleavage stage embryo with >50% difference in blastomere 
diameter and/or >50% fragmentation 
Blastocyst stage embryos with few cells forming the inner cell 
mass and very few cells making up the trophectoderm 
Definitions of embryo quality used to classify embryos as good, average and poor quality 
based on ACE/BFS embryo grading guidelines (Cutting et al., 2008).  
Supplementary table 2 
 
 
 
 Abnormal 
embryos 
transferred 
(n) 
Total  
transfers 
(n) 
SET  
(n) 
DET 
(n) 
Cleavage 
stage 
transfers 
(n) 
Blastocyst 
stage 
transfers (n) 
TDC 1 1 1 0 0 1 
FDC 6 6 6 0 0 6 
UDC 16 15 14 1 5 10 
DC 23 22 21 1 5 17 (1xDET) 
RC 9 8 7 1 2 (1xDET) 6 
AC 4 3 2 1 1 2 (1xDET) 
CC 48 37 26 11 20 
(5xDET) 
17 (6xDET) 
CL 2 2 2 0 0 2 
Overall 86 72 58 14 28 44 
Embryo transfer baseline information for each abnormal embryo phenotype 
including the total number of transfers, the number of single embryo 
transfers (SET), double embryo transfers (DET), cleavage stage transfers 
and blastocyst stage transfers.  
